Teveten · DIN 02243942 · 600 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2023-09-18 — choose a marketed DIN from the same-category list.Discontinued September 18, 2023 · checked November 19, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2023-09-18 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2023-09-18 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Teveten · DIN 02243942
Manufacturer: Solvay Pharma Inc.; listing date 2002-07-29
Health Canada: Cancelled post market since 2023-09-18 · brand TEVETEN · ATC C09CA02 EPROSARTAN · form Tablet · route Oral · ingredients EPROSARTAN (EPROSARTAN MESYLATE) 600 MG · company Bgp pharma ulc · schedule Prescription
Teveten: Formulary list price $1.19 per unit (the source does not state the unit; exact figure $1.1910). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02243942)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02243942).
DIN 02243942: Teveten
Raw flags: chronicUseMed=Y, dinStatus=E, sec3=Y
Item: 240800252; group id 325; item number 0724; lccId None; manufacturer id SPH
Source form: Tab; strength: 600mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit); DIN status E, meaning unconfirmed
Source prices (unrounded): $1.1910; ministry $1.1910
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02243942
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=67885
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since September 18, 2023 — choose a marketed DIN from the same-category list.